IGF2 and meningioma: IGF-2-mediated Akt phosphorylation was also strongly blocked by GSK1838705A, ceritinib and linsitinib suggesting that the mechanism by which these drugs inhibit meningioma cell growth is mainly via IGF1R blockade.